111 related articles for article (PubMed ID: 21839821)
1. OPA quantification of amino groups at the surface of lipidic nanocapsules (LNCs) for ligand coupling improvement.
Perrier T; Fouchet F; Bastiat G; Saulnier P; Benoît JP
Int J Pharm; 2011 Oct; 419(1-2):266-70. PubMed ID: 21839821
[TBL] [Abstract][Full Text] [Related]
2. Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms.
Perrier T; Saulnier P; Fouchet F; Lautram N; Benoît JP
Int J Pharm; 2010 Aug; 396(1-2):204-9. PubMed ID: 20600733
[TBL] [Abstract][Full Text] [Related]
3. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP
Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115
[TBL] [Abstract][Full Text] [Related]
4. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X
ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354
[TBL] [Abstract][Full Text] [Related]
5. Entrance effects at nanopores of nanocapsules functionalized with poly(ethylene glycol) and their flow through nanochannels.
Popa R; Vrânceanu M; Nikolaus S; Nirschl H; Leneweit G
Langmuir; 2008 Nov; 24(22):13030-6. PubMed ID: 18950201
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133.
Bourseau-Guilmain E; Béjaud J; Griveau A; Lautram N; Hindré F; Weyland M; Benoit JP; Garcion E
Int J Pharm; 2012 Feb; 423(1):93-101. PubMed ID: 21683129
[TBL] [Abstract][Full Text] [Related]
7. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
Morille M; Montier T; Legras P; Carmoy N; Brodin P; Pitard B; Benoît JP; Passirani C
Biomaterials; 2010 Jan; 31(2):321-9. PubMed ID: 19800113
[TBL] [Abstract][Full Text] [Related]
8. Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies.
Anwar M; Akhter S; Mallick N; Mohapatra S; Zafar S; Rizvi MMA; Ali A; Ahmad FJ
Pharmacol Res; 2016 Nov; 113(Pt A):146-165. PubMed ID: 27546165
[TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model.
David S; Carmoy N; Resnier P; Denis C; Misery L; Pitard B; Benoit JP; Passirani C; Montier T
Int J Pharm; 2012 Feb; 423(1):108-15. PubMed ID: 21726617
[TBL] [Abstract][Full Text] [Related]
10. Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting.
Morille M; Passirani C; Letrou-Bonneval E; Benoit JP; Pitard B
Int J Pharm; 2009 Sep; 379(2):293-300. PubMed ID: 19505548
[TBL] [Abstract][Full Text] [Related]
11. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
[TBL] [Abstract][Full Text] [Related]
12. siRNA LNCs--a novel platform of lipid nanocapsules for systemic siRNA administration.
David S; Resnier P; Guillot A; Pitard B; Benoit JP; Passirani C
Eur J Pharm Biopharm; 2012 Jun; 81(2):448-52. PubMed ID: 22381204
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and genotoxicity of lipid nanocapsules.
Le Roux G; Moche H; Nieto A; Benoit JP; Nesslany F; Lagarce F
Toxicol In Vitro; 2017 Jun; 41():189-199. PubMed ID: 28323104
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of surface deformability of lipid nanocapsules by drop tensiometer technique, and its experimental assessment by dialysis and tangential flow filtration.
Hirsjärvi S; Bastiat G; Saulnier P; Benoît JP
Int J Pharm; 2012 Sep; 434(1-2):460-7. PubMed ID: 22698864
[TBL] [Abstract][Full Text] [Related]
15. Radiolabeling and targeting of lipidic nanocapsules for applications in radioimmunotherapy.
Jestin E; Mougin-Degraef M; Faivre-Chauvet A; Remaud-Le Saëc P; Hindre F; Benoit JP; Chatal JF; Barbet J; Gestin JF
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):51-60. PubMed ID: 17372573
[TBL] [Abstract][Full Text] [Related]
16. Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion.
Anton N; Gayet P; Benoit JP; Saulnier P
Int J Pharm; 2007 Nov; 344(1-2):44-52. PubMed ID: 17592746
[TBL] [Abstract][Full Text] [Related]
17. Effect of O/S/W process parameters on 17beta-EV loaded nanoparticles properties.
Khoee S; Hossainzadeh MT
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):133-40. PubMed ID: 19740631
[TBL] [Abstract][Full Text] [Related]
18. Tumor transfection after systemic injection of DNA lipid nanocapsules.
Morille M; Passirani C; Dufort S; Bastiat G; Pitard B; Coll JL; Benoit JP
Biomaterials; 2011 Mar; 32(9):2327-33. PubMed ID: 21185595
[TBL] [Abstract][Full Text] [Related]
19. Surface active properties of lipid nanocapsules.
Mouzouvi CRA; Umerska A; Bigot AK; Saulnier P
PLoS One; 2017; 12(8):e0179211. PubMed ID: 28796777
[TBL] [Abstract][Full Text] [Related]
20. Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.
Huynh NT; Morille M; Bejaud J; Legras P; Vessieres A; Jaouen G; Benoit JP; Passirani C
Pharm Res; 2011 Dec; 28(12):3189-98. PubMed ID: 21691892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]